HeartLogic Allows Intense Remote Monitoring of Patient After Implantation of VIGILANT™ CRT-D
Summary
Age and Gender: 68-year-old female
Device Used: VIGILANT™ CRT-D
Patient History: Dilated cardiomyopathy, severe mitral regurgitation, second-degree heart block (HB) and left bundle branch block (LBBB). Six days prior to implant, patient presented in emergency department with symptoms of malaise/fatigue, dyspnea on exertion and shortness of breath.
- LHC/RHC due to severe heart failure (HF)
- Vitals:
- HR 48
- BP 123/74
- RR 18 O2 Sat 89% (6L nasal cannula)
- Weight 63kg (139lb)
- Admitted for 25 days
Timeline Prior to Alert:
Day 1: VIGILANT CRT-D Implanted
Day 12: Patient continues to have volume overload secondary to Acute/Chronic HF IV treatment:
- Furosemide (LASIX®) infuse 5mg/hr
- Milrinone (PRIMACOR®) infuse 23.1375 mcg/min
Day 21: Discharged
- ACC/AHA stage D heart failure
Cardiac Medications:
- Lisinopril 10mg BID – reduced from 30mg qd
- Metoprolol (TOPROL-XL®) 100mg daily - increase from baseline
- ALDACTONE® 25mg daily – new
Day 34: Follow-up with CHF Clinic and Device Clinic
- Start PRN diuretic Demadex® 10mg daily
- Standard protocol for this clinic
- Standard protocol for this clinic
(A) Day 42: HeartLogic Alert Level 17
Home Health RN:
- Reports fever and non-productive cough
Medication Change:
- None
(B) Day 49: Alert Level 50
Home Health RN:
- Weight Assessment +2 lb gain
- Patient has SOB and edema
Medication Change:
- Demadex® 10mg x 1 per protocol
(C) Day 58: Alert Level 56
- Patient has edema and SOB
- Demadex® 10mg M W F
(D) Day 63: Alert Level 58
Nurse Practitioner Visit:
- +3 lb weight gain
- Demadex® 10mg daily
(E) Day 98: Alert Level 16
- Lisinopril Discontinued
- Entresto® 49/51mg started
(F) Day 104: Alert Level 0
- No SOB or edema noted
- Patient states “I’m feeling much better and have started walking around the block again”
- Continue remote monitoring with HeartLogic
Clinical Data
HeartLogic™ Heart Failure Index
(A) Day 42: Alert Level 17
Home Health RN:
- Reports fever and non-productive cough
- Patient ER visit; discharged with non-productive cough
Medication Change:
- None
- BNP = 1,236
- Previous BNP = 2,272 (5 months earlier)
(B) Day 49: Alert Level 50
Home Health RN:
- Weight Assessment
- Weight = 124.35 lbs
- Patient has SOB and edema
Medication Change:
- Demadex® 10mg x 1 per protocol
HeartLogicTM Heart Failure Index
(C) Day 58: Alert Level 56
- Patient has edema and SOB
- Demadex® 10mg M W F
(D) Day 63: Alert Level 58
Nurse Practitioner Visit:
- Weight = 127 pounds
- Demadex® 10mg daily
(E) Day 98: Alert Level 16
- Weight = 127 pounds
- Lisinopril Discontinued
- Entresto® 49/51mg started
(F) Day 104: Alert Level 0
Patient will continue to follow-up with CHF Clinic and Device Clinic
- May 22 – Office visit with CHF clinic
- Weight = 124lbs
- No SOB or edema noted
- Patient states “I’m feeling much better and have started walking around the block again”
- Continue remote monitoring with HeartLogic
Explore More Case Studies
Find out how HeartLogic alerted physicians of worsening heart failure (HF) a day after a patient’s follow-up visit.
See how a proactive device check discovered an increasing HeartLogic score and led to a medication change.
Discover the importance of a multi-sensor approach in evaluating worsening heart failure.